Title
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma
Date Issued
13 May 2000
Access level
metadata only access
Resource Type
journal article
Author(s)
Leung D.Y.M.
Thatayatikom A.
Streib J.E.
Price M.R.
Klinnert M.D.
Liu A.H.
Univ. of Colorado Hlth. Sci. Center
Publisher(s)
Elsevier B.V.
Abstract
Background. Bacterial endotoxin is known to induce interferon γ and interleukin 12 production, and therefore has the potential to decrease allergen sensitisation. To find out the role of early chronic endotoxin exposure in the development of allergen sensitisation and asthma, we compared concentrations of endotoxin in house dust with allergen sensitisation in infants at high risk for developing asthma. Methods. 61 infants 9-24 months old with at least three physician-documented episodes of wheezing were studied. Concentrations of house-dust endotoxin and allergens were measured in the infants' homes. Allergen sensitisation was measured by skin-prick testing with a panel of common inhalant and food allergens. In a subset of these infants. proportions of T lymphocytes producing interferon γ, and interleukins 4, 5, and 13 were calculated by cell-surface and intracellular cytokine staining, with flow cytometry. Findings. House-dust endotoxin concentrations ranged from 104 to 10,000 endotoxin units (EU) per mL (geometric mean 912 EU/mL). Concentrations did not vary significantly over a 6-month interval. Ten infants (16%) were sensitised to at least one allergen. The homes of allergen-sensitised infants contained significantly lower concentrations of house-dust endotoxin than those of non-sensitised infants (mean 468 vs 1035 EU/mL, respectively; p = 0.01). Increased house-dust endotoxin concentrations correlated with increased proportions of interferon-γ-producing CD4 T cells (p = 0.01). Such concentrations did not correlate with proportions of cells that produced interleukins 4, 5, or 13. Interpretation. This study may provide the first direct in-vivo evidence that indoor endotoxin exposure early in life may protect against allergen sensitisation by enhancing type 1 immunity.
Start page
1680
End page
1683
Volume
355
Issue
9216
Language
English
OCDE Knowledge area
Epidemiología
Inmunología
Scopus EID
2-s2.0-0034643729
PubMed ID
Source
Lancet
ISSN of the container
01406736
Sponsor(s)
We thank William Townend and Shirley Sobus for technical support in the National Jewish Flow Cytometry facility; May Gillespie for technical support with the endotoxin assay; Tina Nealy for assistance with infant phlebotomy, the General Clinical Research Center for biostatistical support; Jan Manzanares for assistance in preparing the paper. This study was supported by the US National Institutes of Health (grants R18AI41137, M01-RR00051, and HL-36577); the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; the American Lung Association; and the National Jewish Medical & Research Center.
Sources of information:
Directorio de Producción Científica
Scopus